100 related articles for article (PubMed ID: 17684496)
1. Conformationally altered p53: a novel Alzheimer's disease marker?
Lanni C; Racchi M; Mazzini G; Ranzenigo A; Polotti R; Sinforiani E; Olivari L; Barcikowska M; Styczynska M; Kuznicki J; Szybinska A; Govoni S; Memo M; Uberti D
Mol Psychiatry; 2008 Jun; 13(6):641-7. PubMed ID: 17684496
[TBL] [Abstract][Full Text] [Related]
2. Conformationally altered p53: a putative peripheral marker for Alzheimer's disease.
Uberti D; Lanni C; Racchi M; Govoni S; Memo M
Neurodegener Dis; 2008; 5(3-4):209-11. PubMed ID: 18322392
[TBL] [Abstract][Full Text] [Related]
3. Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients.
Uberti D; Lanni C; Carsana T; Francisconi S; Missale C; Racchi M; Govoni S; Memo M
Neurobiol Aging; 2006 Sep; 27(9):1193-201. PubMed ID: 16165254
[TBL] [Abstract][Full Text] [Related]
4. P53-mediated G(1)/S checkpoint dysfunction in lymphocytes from Alzheimer's disease patients.
Zhou X; Jia J
Neurosci Lett; 2010 Jan; 468(3):320-5. PubMed ID: 19914341
[TBL] [Abstract][Full Text] [Related]
5. Alteration of protein kinase C conformation in red blood cells: a potential marker for Alzheimer's disease but not for Parkinson's disease.
Janoshazi A; Sellal F; Marescaux C; Danion JM; Warter JM; de Barry J
Neurobiol Aging; 2006 Feb; 27(2):245-51. PubMed ID: 15893856
[TBL] [Abstract][Full Text] [Related]
6. Combination of p53(ser15) and p21/p21(thr145) in peripheral blood lymphocytes as potential Alzheimer's disease biomarkers.
Tan M; Wang S; Song J; Jia J
Neurosci Lett; 2012 May; 516(2):226-31. PubMed ID: 22503900
[TBL] [Abstract][Full Text] [Related]
7. Changes of p53 in the brains of patients with Alzheimer's disease.
Kitamura Y; Shimohama S; Kamoshima W; Matsuoka Y; Nomura Y; Taniguchi T
Biochem Biophys Res Commun; 1997 Mar; 232(2):418-21. PubMed ID: 9125193
[TBL] [Abstract][Full Text] [Related]
8. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
9. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
[TBL] [Abstract][Full Text] [Related]
10. Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease.
Thomas P; O' Callaghan NJ; Fenech M
Mech Ageing Dev; 2008 Apr; 129(4):183-90. PubMed ID: 18242664
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P
Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699
[TBL] [Abstract][Full Text] [Related]
12. Can the rDNA methylation pattern be used as a marker for Alzheimer's disease?
Sperança MA; Batista LM; Lourenço Rda S; Tavares WM; Bertolucci PH; Rigolin Vde O; Payão SL; Smith Mde A
Alzheimers Dement; 2008 Nov; 4(6):438-42. PubMed ID: 19012869
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
[TBL] [Abstract][Full Text] [Related]
14. A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia.
Cummings J; Winblad B
Expert Rev Neurother; 2007 Nov; 7(11):1457-63. PubMed ID: 17997695
[TBL] [Abstract][Full Text] [Related]
15. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
[TBL] [Abstract][Full Text] [Related]
16. A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia.
Simonsen AH; McGuire J; Podust VN; Hagnelius NO; Nilsson TK; Kapaki E; Vassilopoulos D; Waldemar G
Dement Geriatr Cogn Disord; 2007; 24(6):434-40. PubMed ID: 17971664
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
Palumbo B; Siepi D; Sabalich I; Tranfaglia C; Parnetti L
Funct Neurol; 2008; 23(2):93-6. PubMed ID: 18671910
[TBL] [Abstract][Full Text] [Related]
18. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
Song IU; Kim JS; Yoo JY; Song HJ; Lee KS
Eur Neurol; 2008; 59(1-2):49-54. PubMed ID: 17917458
[TBL] [Abstract][Full Text] [Related]
19. Searching for predictive blood biomarkers: misfolded p53 in mild cognitive impairment.
Stanga S; Lanni C; Sinforiani E; Mazzini G; Racchi M
Curr Alzheimer Res; 2012 Dec; 9(10):1191-7. PubMed ID: 22746246
[TBL] [Abstract][Full Text] [Related]
20. Education plays a different role in Frontotemporal Dementia and Alzheimer's disease.
Borroni B; Alberici A; Agosti C; Premi E; Padovani A
Int J Geriatr Psychiatry; 2008 Aug; 23(8):796-800. PubMed ID: 18172915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
